| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Frohlich Tom is a Chief Executive Officer at Jade Biosciences, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $101K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | JBIO Jade Biosciences, Inc. | Chief Executive Officer | Buy | 6,000 | $7.40 | $44,400.00 | New | -7.8% | +218.0% |